
Trulieve Cannabis Corp.
TCNNF
Updated: 23/09/2026, 20:57:51
Trulieve Cannabis Corporation, along with its various subsidiaries, functions as a prominent medical marijuana enterprise. This company manages the entire production cycle, from cultivating its own cannabis to manufacturing finished goods in-house. Its products are then distributed directly to consumers through Trulieve-branded dispensaries located in Florida, with the added convenience of home delivery services within the state. Trulieve boasts a wide array of cannabis product types, including traditional flower, edibles, vaporizer cartridges, concentrates, topical applications, capsules, tinctures, dissolvable powders, and even nasal sprays. These are offered under several proprietary brands, such as Avenue, Cultivar Collection, Muse, Modern Flower, Alchemy, Momenta, Sweet Talk, Co2lors, Loveli, and Roll One. As of March 16, 2022, the company's retail presence included 162 dispensaries across multiple states. This network comprised 113 stores in Florida, 19 affiliated locations in Pennsylvania, 17 in Arizona, 5 in California, 3 in Maryland, 2 each in Massachusetts and West Virginia, and one in Connecticut. Beyond retail, Trulieve Cannabis Corp. also operates cultivation and processing facilities in Arizona, Colorado, Florida, Maryland, Massachusetts, Nevada, Pennsylvania, and West Virginia. Tracing its origins back to an incorporation in 1940, the company was initially known as Schyan Exploration Inc./Exploration Schyan Inc. It officially adopted the name Trulieve Cannabis Corp. in September 2018 and maintains its headquarters in Quincy, Florida.
No summaries found.
- Share price
- $12.52
- Market cap
- $2.41B
- Exchange
- OTC
- Currency
- USD
- CEO
- Kimberly Rivers
- Employees
- 6,000
- IPO date
- 27/09/2018
- Beta
- 1.677
- Last dividend
- $0.00
- Day range
- $12.33 – $12.52
- 52-week range
- $7.92 – $13.28
- 1-day performance
- 1.38%
- 1-year performance
- 58.08%
- Current drawdown (1Y)
- -5.72%
- CIK
- 0001754195
- CUSIP
- 89788C104
- ISIN
- CA89788C1041
- Created
- 07/12/2025, 14:30:32
- Last update
- 23/09/2026, 20:57:51
Track Trulieve Cannabis Corp. with an AI analyst
See which prediction-market events move TCNNF, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
Trulieve Announces Uplist to NYSE
PRNewsWire • STOCK • 05/06/2026, 09:00:00
Trulieve Could Benefit From Uplisting To Major Index
Seeking Alpha • STOCK • 18/05/2026, 02:10:22
Trulieve Announces Proposed Domestication from British Columbia to Delaware
PRNewsWire • STOCK • 13/05/2026, 18:46:00
Trulieve Cannabis Corp. (OTC: TCNNF) Stock Transaction and Q1 2026 Performance Amidst Rescheduling
Market Data • Market Data • 08/05/2026, 17:07:31
Trulieve Cannabis Corp. (TCNNF) Q1 2026 Earnings Call Transcript
Seeking Alpha • STOCK • 08/05/2026, 04:01:18
Trulieve Reports Profitable First Quarter 2026 Results Bolstered by Margins and Cash Flow Generation
PRNewsWire • STOCK • 07/05/2026, 08:15:00
Trulieve Applauds Trump Administration For Rescheduling Medical Marijuana to Schedule III
PRNewsWire • STOCK • 23/04/2026, 10:45:00
Trulieve Announces Executive Automatic Securities Disposition Plan
PRNewsWire • STOCK • 17/03/2026, 18:59:00
Trulieve: Q4 Results Show Strong Balance Sheet, But Sector Uncertainty Remains
Seeking Alpha • STOCK • 02/03/2026, 13:29:54
Trulieve Reports Fourth Quarter and Full Year 2025 Results with 60% Gross Margin and Record Cash Flow Generation
PRNewsWire • STOCK • 26/02/2026, 07:15:00